Smith Anglin Financial, LLC

SEC CIK: 0001553540
Latest filing: Jul 17, 2025

SEC filings (opens in a new tab)

CNSP holding history

CNS Pharmaceuticals, Inc. in every 13F filed by Smith Anglin Financial, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CNSP overview All 13F holders of CNSP Full Q2 2025 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of CNSP by Smith Anglin Financial, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−90,332−100.0%	Sold out	Holders
Q1 2024	90,332	$32.7K	<0.1%	+40,332+80.7%	Added	Holders
Q4 2023	50,000	$63.5K	<0.1%	+50,000	New	Holders